AI-Driven De Novo Design of Ultra Long-Acting GLP-1 Receptor Agonists.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- AI-Driven De Novo Design of Ultra Long-Acting GLP-1 Receptor Agonists.
- Published In:
- Advanced science (Weinheim, Baden-Wurttemberg, Germany), 12(40), e07044 (2025)
- Authors:
- Wei, Ting, Ma, Jiating, Cui, Xiaochen, Lin, Jiahui, Zheng, Zhuoqi, Cheng, Liu, Cui, Taiying, Lin, Xiaoqian, Zhu, Junjie, Ran, Xuyang, Hong, Xiaokun, Johnston, Luke, Yu, Zhangsheng, Chen, Haifeng
- Database ID:
- RPEP-14109
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-14109APA
Wei, Ting; Ma, Jiating; Cui, Xiaochen; Lin, Jiahui; Zheng, Zhuoqi; Cheng, Liu; Cui, Taiying; Lin, Xiaoqian; Zhu, Junjie; Ran, Xuyang; Hong, Xiaokun; Johnston, Luke; Yu, Zhangsheng; Chen, Haifeng. (2025). AI-Driven De Novo Design of Ultra Long-Acting GLP-1 Receptor Agonists.. Advanced science (Weinheim, Baden-Wurttemberg, Germany), 12(40), e07044. https://doi.org/10.1002/advs.202507044
MLA
Wei, Ting, et al. "AI-Driven De Novo Design of Ultra Long-Acting GLP-1 Receptor Agonists.." Advanced science (Weinheim, 2025. https://doi.org/10.1002/advs.202507044
RethinkPeptides
RethinkPeptides Research Database. "AI-Driven De Novo Design of Ultra Long-Acting GLP-1 Receptor..." RPEP-14109. Retrieved from https://rethinkpeptides.com/research/wei-2025-aidriven-de-novo-design
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.